accountObjective: The chemotherapeutic agent mitoxantrone was approved for use in multiple sclerosis (MS) in 2000. After a review of all the available...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Evidence Report: The efficacy and safety of mitoxantrone...
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account